Personalized treatment of Sézary syndrome by targeting a novelCTLA4:CD28fusion
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Personalized treatment of Sézary syndrome by targeting a novelCTLA4:CD28fusion
Authors
Keywords
-
Journal
Molecular Genetics & Genomic Medicine
Volume 3, Issue 2, Pages 130-136
Publisher
Wiley
Online
2014-11-28
DOI
10.1002/mgg3.121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
- (2012) D. W. Craig et al. MOLECULAR CANCER THERAPEUTICS
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
- (2011) Neesar Ahmed et al. NATURE IMMUNOLOGY
- BRAFMutations in Hairy-Cell Leukemia
- (2011) Enrico Tiacci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
- (2010) Elise A. Olsen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma
- (2010) Elodie Laharanne et al. MODERN PATHOLOGY
- CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch
- (2010) Holger Hoff et al. MOLECULAR IMMUNOLOGY
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
- (2010) Cole Trapnell et al. NATURE BIOTECHNOLOGY
- Genetic determinants at the interface of cancer and neurodegenerative disease
- (2010) L G T Morris et al. ONCOGENE
- Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2
- (2010) T. Mund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice
- (2010) G. Poulogiannis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TopHat: discovering splice junctions with RNA-Seq
- (2009) Cole Trapnell et al. BIOINFORMATICS
- Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins
- (2009) Thomas Mund et al. EMBO REPORTS
- Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
- (2009) Selvaraju Veeriah et al. NATURE GENETICS
- Accurate whole human genome sequencing using reversible terminator chemistry
- (2008) David R. Bentley et al. NATURE
- The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20
- (2008) Noula Shembade et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now